|
TBL1XR1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.32540000039339E-07 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.68189999997182E-07 |
| Normal-vs-Stage2 |
1.703500E-02 |
| Normal-vs-Stage3 |
4.191300E-04 |
| Normal-vs-Stage4 |
4.997100E-04 |
| Stage1-vs-Stage2 |
7.657400E-01 |
| Stage1-vs-Stage3 |
8.796600E-01 |
| Stage1-vs-Stage4 |
3.212200E-01 |
| Stage2-vs-Stage3 |
8.609800E-01 |
| Stage2-vs-Stage4 |
8.079600E-01 |
| Stage3-vs-Stage4 |
5.551800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.26869999955903E-07 |
| Normal-vs-AfricanAmerican |
3.140100E-02 |
| Normal-vs-Asian |
2.329700E-02 |
| Caucasian-vs-AfricanAmerican |
2.839800E-01 |
| Caucasian-vs-Asian |
7.763200E-01 |
| AfricanAmerican-vs-Asian |
4.841600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.83909999995624E-06 |
| Normal-vs-Female |
3.16909999997783E-06 |
| Male-vs-Female |
9.698400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.353800E-02 |
| Normal-vs-Age(41-60Yrs) |
2.64630000024191E-07 |
| Normal-vs-Age(61-80Yrs) |
3.93389999999716E-05 |
| Normal-vs-Age(81-100Yrs) |
9.558000E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.185000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.999000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.709600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.295600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.454300E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.955200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.36449999999811E-05 |
| Normal-vs-Grade 2 |
1.05060000032964E-07 |
| Normal-vs-Grade 3 |
1.363360E-04 |
| Normal-vs-Grade 4 |
1.292260E-02 |
| Grade 1-vs-Grade 2 |
2.418400E-01 |
| Grade 1-vs-Grade 3 |
2.643800E-02 |
| Grade 1-vs-Grade 4 |
2.228500E-02 |
| Grade 2-vs-Grade 3 |
2.294100E-02 |
| Grade 2-vs-Grade 4 |
1.678140E-02 |
| Grade 3-vs-Grade 4 |
4.471800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.32319965884653E-10 |
| Normal-vs-ccB subtype |
2.036500E-03 |
| ccA subtype-vs-ccB subtype |
5.198200E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.06669999999642E-06 |
| Normal-vs-N1 |
1.444360E-02 |
| N0-vs-N1 |
8.759200E-01 |
|
|
